Target Group Inc (CBDY) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Target Group Inc $0.00, price $0.00, upside +15.1%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Target Group Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range $0.0006 – $0.0240 · the $0.0007 price screens below the $0.0008 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.
Follow Target Group in your weekly email
Every Wednesday you see whether Target Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Target Group Inc. engages in the cultivation, processing, and distribution of curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.
Show more
Target Group Inc. engages in the cultivation, processing, and distribution of curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States. The company offers cannabis pre-rolls, and flower and extract pods for vaporizer use; K-Cup infused coffee and tea pods; and infused cannabis beverages, edibles, and topical products and CBD wellness products. It also provides a single-use pre-measured pod and vaporizer system for consumers interested in vaporizing natural herbs, including cannabis under The Wisp and Wisp Pods brands. The company was formerly known as Chess Supersite Corporation and changed its name to Target Group Inc. in July 2018. Target Group Inc. was incorporated in 2013 and is based in Hamilton, Canada.
Stock analysis
Target Group Inc (CBDY) currently trades at $0.0007, while our model-based Fair Value estimate is $0.0008, implying the stock looks roughly 13.1% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 5 models at a data quality of 95/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Target Group Inc reported revenue of $3.9M in FY2025 versus $0 in FY2021. Reported net income was −$1.4M in FY2025.
Key figures
Market cap $926K · P/S ratio 0.28 · Net margin −35.0% · Return on equity −2,305% · Return on assets (EBIT) 8.1% · Operating margin −33.8% · Revenue (TTM) $3.4M · Revenue growth (YoY) −37.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (medium confidence).
What moves the price
The share trades about 77% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 15%, CBDY screens cheaper than that median.
Fair Value models
Bear $0.0008Fair Value $0.0008Bull $0.0008
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.33/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+194.0%
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+140.4%
’16
’17
’19
’20
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−15,633.3% (2019) → 17.0% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 585 stocks
Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score33 · Bottom 25%
Fair Value upside+15.1% · Above median
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets−6.5% · Bottom 25%
Net margin (TTM)−53.6% · Bottom 25%
Operating margin (TTM)−33.8% · Bottom 25%
Growth and dividend
Revenue growth−37.2% · Bottom 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)0.28× · Cheapest 25%
EV/EBITDA3.4× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)53· sector 14
FUTURE (revenue growth)0· sector 24
PAST (return on equity)0· sector 28
HEALTH (low debt)0· sector 96
DIVIDEND (yield)0· sector 31
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Target Group Inc Fair Value". https://www.fairvalue-calculator.com/stock/CBDY
Frequently asked questions
Is Target Group Inc (CBDY) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0008 versus a price of $0.0007, about +15% upside (undervalued).
What is the fair value of CBDY?
Our model-based fair value for Target Group Inc is $0.0008 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0007.
What is the quality score of CBDY?
Target Group Inc has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Target Group Inc (CBDY)?
Our model-based price target is the fair value of $0.0008 (as of Sep 27, 2026) from 5 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Target Group Inc stock forecast for 2026?
Our models put fair value at $0.0008, about +15% upside versus a price of $0.0007 (undervalued). The calculation is refreshed regularly with new filings.
What is the revenue of Target Group Inc (CBDY)?
Target Group Inc reported trailing-twelve-month revenue of about $3.4M (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Target Group Inc (CBDY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Target Group Inc it is $0.0008 per share (as of Sep 27, 2026), against a price of $0.0007. It is the blended result of 5 valuation models (cash flow, earnings, asset, dividend).
Is Target Group Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, CBDY trades below its calculated fair value: price $0.0007, fair value $0.0008, a gap of about +15% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CBDY?
No. The price is what the market pays today ($0.0007); the fair value is what the company's own numbers justify ($0.0008). For Target Group Inc the two are $0.0001 per share apart. That gap is exactly why we show both numbers side by side.
How much is Target Group Inc worth?
The market values Target Group Inc at about $926K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0007; our models calculate a fair value of $0.0008 per share.
How solid is the balance sheet of Target Group Inc (CBDY)?
Balance-sheet figures for Target Group Inc (as of Sep 27, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is CBDY from its 52-week high?
Target Group Inc trades at $0.0007, about 77% below its 52-week high of $0.0030 and 17% above the low of $0.0006 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0008 is for.
Which stocks are comparable to Target Group Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Target Group Inc stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0007, calculated fair value $0.0008 (+15%), Quality Score 33/100, from 5 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CBDY calculated?
We run Target Group Inc through 5 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0008, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Target Group Inc currently trades 13 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Target Group Inc (CBDY)?
The closing price on Oct 1, 2026 was $0.0007. Our model-based fair value is $0.0008, about +15% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Target Group Inc right now?
The price is below even our cautious bear case ($0.0008). The market is more pessimistic than our downside scenario. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Target Group Inc
How large is the market capitalisation of Target Group Inc (CBDY)?
The market capitalisation of Target Group Inc is $926K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Target Group Inc (CBDY)?
The price-to-sales ratio of Target Group Inc is 0.28 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Target Group Inc (CBDY)?
The net margin of Target Group Inc is −35.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Target Group Inc (CBDY)?
The return on equity (ROE) of Target Group Inc is −2,305% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Target Group Inc (CBDY)?
On an EBIT basis the return on assets of Target Group Inc is 8.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Target Group Inc (CBDY)?
The operating margin of Target Group Inc is −33.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Target Group Inc (CBDY)?
Revenue at Target Group Inc is growing −37.2% versus a year earlier (3y avg −8.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Target Group Inc (CBDY)?
Earnings per share at Target Group Inc are growing −30.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Target Group Inc (CBDY) generate?
The free cash flow of Target Group Inc is −$917K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Target Group Inc (CBDY) carry?
The net debt of Target Group Inc is $933K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Target Group Inc in the live analysis
One click puts Target Group Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026